IRBM is an innovative research organization with decades of experience in translating nascent research into drug discovery programs. Our unique blend of broad expertise, global pharma heritage and passion for science successfully helps advance and accelerate your therapeutics from conception to the clinic. We have delivered over 25 candidates to the clinic, and over 800 patents are attributed to our scientists. Our unremitting, solid and science-driven dedication to the development of novel drugs is certified by our past and present achievements: four of our candidates are now marketed drugs and two are currently entering the early stage of clinical development. Utilizing the know-how and talent responsible for this unprecedented track record, we can fully support your research, providing you with robust data to move forward to the next phase of your project. We will accelerate your drug discovery with our expertise in small molecules, peptides and antibody therapeutics. With capabilities ranging from target validation to clinical candidate nomination, we bring great science to your project at every stage. Thanks to our diverse range of expertise, your program can benefit from being developed at IRBM as an integrated project, or by having us support smaller, stand-alone projects. All R&D is carried out under one roof in our state-of-the-art facilities, enabling us to seamlessly transition between disciplines and ensuring faster turn-around times. All projects are matched with a team of highly adaptable scientists and a dedicated project representative to create tailor-made solutions, customized to your evolving needs. Find more detailed information available on our website below.